Phase I Study of TBI-1401(HF10) Plus Chemotherapy in Patients with Unresectable Pancreatic Cancer.
Clinical trial NCT03252808 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03252808
- Sponsor
- Takara Bio Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-25
- Primary completion
- 2020-02-19
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.